Featured

Chinaplas: Starlinger Presents Circular Economy Solutions for Plastic Packaging The Austrian technology leader for woven plastic packaging production and supplier of plastics recycling systems sets the focus on circular packaging solutions…

How Yes Bank Plans to Onboard Paytm Merchants After NPCI Yes for 3rd-Party App Licence

Delhi Court Grants Bail to Arvind Kejriwal in Liquor Scam Case ED had filed two complaints before the magisterial court seeking Kejriwal's prosecution for skipping multiple summonses issued to him in the case Delhi's Rouse Avenue Court…

Eris Lifesciences Enters Rs 30,000 Cr Injectables Market With Biocon Biologics Acquisition The acquisition brings two leading insulin products, Basalog and Insugen, under Eris’s umbrella. Indian branded formulations pharmaceutical…

Bank Of Maharashtra, Iob Among 5 Psbs Planning to Cut Govt Stake to Meet Sebi Norms The Minimum Public Shareholding (MPS) norm mandates at least 25 per cent public float for all listed companies. A blanket exemption was given to some PSUs…

Rare 4GB Original Iphone Hits Auction Block, Expected To Fetch A High Price Recent auctions have witnessed staggering bids, with one such device commanding an eye-watering $190,000. In a nostalgic turn of events, the iconic 2007 Apple…

Updated Itr: Deadline to File Updated Returns for Fy21 is March 31. Check How to File Taxpayers won't be asked to pay a penalty or additional fee to fill the ITR-U. However, they will have to pay an additional tax as per Section 140B of…

'Valuation Concerns': ICICI Prudential Halts Lump Sum Flow Into Small, Mid Cap Schemes The move comes after the Securities and Exchange Board of India (Sebi) red-flagged build-up of froth in the midcap and smallcap space. ICICI…

RBI imposes penalty on Bank of India, Bandhan Bank. Details here In all cases, the penalties were imposed for deficiencies in regulatory compliance and is not intended to pronounce upon the validity of any transaction or agreement entered…

Ranjit Shahani, Pharma Veteran And Former VC, MD Of Novartis India, Passes Away Shahani, 74, was Novartis’ India chief when the Swiss drugmaker was involved in a brutal 7-year patent battle over its blood cancer drug Glivec. Former…